These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Nelfinavir (Viracept) expanded access announced.
    Journal: AIDS Treat News; 1996 Sep 20; (No 255):4. PubMed ID: 11363837.
    Abstract:
    Agouron Pharmaceuticals, Inc. began an expanded-access program for nelfinavir, an experimental protease inhibitor. Qualified patients must be HIV-positive, at least 13 years of age, and have a CD4 count less than or equal to 50. Applicants may not have used nelfinavir previously and must be unable to use existing protease inhibitors.
    [Abstract] [Full Text] [Related] [New Search]